Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival.

Kellish P, Shabashvili D, Rahman MM, Nawab A, Guijarro MV, Zhang M, Cao C, Moussatche N, Boyle T, Antonia S, Reinhard M, Hartzell C, Jantz M, Mehta HJ, McFadden G, Kaye FJ, Zajac-Kaye M.

J Clin Invest. 2019 Apr 29;129(6):2279-2292. doi: 10.1172/JCI121323. eCollection 2019 Apr 29.

2.

Characterization of mule deerpox virus in Florida white-tailed deer fawns expands the known host and geographic range of this emerging pathogen.

Sayler KA, Subramaniam K, Jacob JM, Loeb JC, Craft WF, Farina LL, Stacy NI, Moussatche N, Cook L, Lednicky JA, Wisely SM, Waltzek TB.

Arch Virol. 2019 Jan;164(1):51-61. doi: 10.1007/s00705-018-3991-7. Epub 2018 Sep 21.

PMID:
30238163
3.

Keystone Virus Isolated From a Florida Teenager With Rash and Subjective Fever: Another Endemic Arbovirus in the Southeastern United States?

Lednicky JA, White SK, Stephenson CJ, Cherabuddi K, Loeb JC, Moussatche N, Lednicky A, Morris JG Jr.

Clin Infect Dis. 2019 Jan 1;68(1):143-145. doi: 10.1093/cid/ciy485.

PMID:
29893806
4.

High Initial Sputter Rate Found for Vaccinia Virions Using Isotopic Labeling, NanoSIMS, and AFM.

Gates SD, Condit RC, Moussatche N, Stewart BJ, Malkin AJ, Weber PK.

Anal Chem. 2018 Feb 6;90(3):1613-1620. doi: 10.1021/acs.analchem.7b02786. Epub 2018 Jan 19.

PMID:
29295620
5.

Protein Primary Structure of the Vaccinia Virion at Increased Resolution

Ngo T, Mirzakhanyan Y, Moussatche N, Gershon PD.

J Virol. 2016 Oct 14;90(21):9905-9919. doi: 10.1128/JVI.01042-16. Print 2016 Nov 1.

6.

An improved high pressure freezing and freeze substitution method to preserve the labile vaccinia virus nucleocapsid.

Jesus DM, Moussatche N, Condit RC.

J Struct Biol. 2016 Jul;195(1):41-8. doi: 10.1016/j.jsb.2016.05.001. Epub 2016 May 4.

PMID:
27155322
7.

Genomic Analysis, Phenotype, and Virulence of the Historical Brazilian Smallpox Vaccine Strain IOC: Implications for the Origins and Evolutionary Relationships of Vaccinia Virus.

Medaglia ML, Moussatché N, Nitsche A, Dabrowski PW, Li Y, Damon IK, Lucas CG, Arruda LB, Damaso CR.

J Virol. 2015 Dec;89(23):11909-25. doi: 10.1128/JVI.01833-15. Epub 2015 Sep 16.

8.

The vaccinia virus E6 protein influences virion protein localization during virus assembly.

Condit RC, Moussatche N.

Virology. 2015 Aug;482:147-56. doi: 10.1016/j.virol.2015.02.056. Epub 2015 Apr 10.

9.

Vaccinia virus protein A3 is required for the production of normal immature virions and for the encapsidation of the nucleocapsid protein L4.

Jesus DM, Moussatche N, McFadden BB, Nielsen CP, D'Costa SM, Condit RC.

Virology. 2015 Jul;481:1-12. doi: 10.1016/j.virol.2015.02.020. Epub 2015 Mar 9.

10.

Fine structure of the vaccinia virion determined by controlled degradation and immunolocalization.

Moussatche N, Condit RC.

Virology. 2015 Jan 15;475:204-18. doi: 10.1016/j.virol.2014.11.020. Epub 2014 Dec 8.

11.

Vaccinia virus mutations in the L4R gene encoding a virion structural protein produce abnormal mature particles lacking a nucleocapsid.

Jesus DM, Moussatche N, Condit RC.

J Virol. 2014 Dec;88(24):14017-29. doi: 10.1128/JVI.02126-14. Epub 2014 Sep 24.

12.

Identification of immune and viral correlates of norovirus protective immunity through comparative study of intra-cluster norovirus strains.

Zhu S, Regev D, Watanabe M, Hickman D, Moussatche N, Jesus DM, Kahan SM, Napthine S, Brierley I, Hunter RN 3rd, Devabhaktuni D, Jones MK, Karst SM.

PLoS Pathog. 2013;9(9):e1003592. doi: 10.1371/journal.ppat.1003592. Epub 2013 Sep 5.

13.

Vaccinia virions deficient in transcription enzymes lack a nucleocapsid.

McFadden BD, Moussatche N, Kelley K, Kang BH, Condit RC.

Virology. 2012 Dec 5;434(1):50-8. doi: 10.1016/j.virol.2012.08.019. Epub 2012 Sep 1.

14.

Myxoma virus M064 is a novel member of the poxvirus C7L superfamily of host range factors that controls the kinetics of myxomatosis in European rabbits.

Liu J, Wennier S, Moussatche N, Reinhard M, Condit R, McFadden G.

J Virol. 2012 May;86(9):5371-5. doi: 10.1128/JVI.06933-11. Epub 2012 Feb 29.

15.

Biological characterization and next-generation genome sequencing of the unclassified Cotia virus SPAn232 (Poxviridae).

Afonso PP, Silva PM, Schnellrath LC, Jesus DM, Hu J, Yang Y, Renne R, Attias M, Condit RC, Moussatché N, Damaso CR.

J Virol. 2012 May;86(9):5039-54. doi: 10.1128/JVI.07162-11. Epub 2012 Feb 15.

16.

Temperature-sensitive mutant in the vaccinia virus E6 protein produce virions that are transcriptionally inactive.

Boyd O, Strahl AL, Rodeffer C, Condit RC, Moussatche N.

Virology. 2010 Apr 10;399(2):221-30. doi: 10.1016/j.virol.2010.01.010. Epub 2010 Feb 8.

17.

The E6 protein from vaccinia virus is required for the formation of immature virions.

Boyd O, Turner PC, Moyer RW, Condit RC, Moussatche N.

Virology. 2010 Apr 10;399(2):201-11. doi: 10.1016/j.virol.2010.01.012. Epub 2010 Feb 8.

18.

Cidofovir inhibits genome encapsidation and affects morphogenesis during the replication of vaccinia virus.

Jesus DM, Costa LT, Gonçalves DL, Achete CA, Attias M, Moussatché N, Damaso CR.

J Virol. 2009 Nov;83(22):11477-90. doi: 10.1128/JVI.01061-09. Epub 2009 Sep 2.

19.

In vitro activity of cidofovir against the emerging Cantagalo virus and the smallpox vaccine strain IOC.

Jesus DM, Moussatché N, Damaso CR.

Int J Antimicrob Agents. 2009 Jan;33(1):75-9. doi: 10.1016/j.ijantimicag.2008.07.015. Epub 2008 Sep 19.

PMID:
18804965
20.

The vaccinia virus F11L gene product facilitates cell detachment and promotes migration.

Morales I, Carbajal MA, Bohn S, Holzer D, Kato SE, Greco FA, Moussatché N, Krijnse Locker J.

Traffic. 2008 Aug;9(8):1283-98. doi: 10.1111/j.1600-0854.2008.00762.x. Epub 2008 Jun 28.

21.

Marker rescue mapping of the combined Condit/Dales collection of temperature-sensitive vaccinia virus mutants.

Kato SE, Moussatche N, D'Costa SM, Bainbridge TW, Prins C, Strahl AL, Shatzer AN, Brinker AJ, Kay NE, Condit RC.

Virology. 2008 May 25;375(1):213-22. doi: 10.1016/j.virol.2008.01.027. Epub 2008 Mar 7.

22.

When good vaccines go wild: Feral Orthopoxvirus in developing countries and beyond.

Moussatché N, Damaso CR, McFadden G.

J Infect Dev Ctries. 2008 Jun 1;2(3):156-73. Review.

23.

Accuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodies.

Borges MB, Kato SE, Damaso CR, Moussatché N, da Silva Freire M, Lambert Passos SR, do Nascimento JP.

Biologicals. 2008 Mar;36(2):105-10. Epub 2007 Sep 24.

PMID:
17892944
24.

The vaccinia virus E8R gene product is required for formation of transcriptionally active virions.

Kato SE, Condit RC, Moussatché N.

Virology. 2007 Oct 25;367(2):398-412. Epub 2007 Jul 9.

25.

A PCR-based assay for detection of emerging vaccinia-like viruses isolated in Brazil.

Damaso CR, Reis SA, Jesus DM, Lima PS, Moussatché N.

Diagn Microbiol Infect Dis. 2007 Jan;57(1):39-46. Epub 2006 Sep 1.

PMID:
16949244
26.

In a nutshell: structure and assembly of the vaccinia virion.

Condit RC, Moussatche N, Traktman P.

Adv Virus Res. 2006;66:31-124. Review.

PMID:
16877059
27.
28.

Effects of diterpenes isolated from the Brazilian marine alga Dictyota menstrualis on HIV-1 reverse transcriptase.

de Souza Pereira H, Leão-Ferreira LR, Moussatché N, Teixeira VL, Cavalcanti DN, da Costa LJ, Diaz R, Frugulhetti IC.

Planta Med. 2005 Nov;71(11):1019-24.

PMID:
16320202
30.

Antiviral activity of diterpenes isolated from the Brazilian marine alga Dictyota menstrualis against human immunodeficiency virus type 1 (HIV-1).

Pereira HS, Leão-Ferreira LR, Moussatché N, Teixeira VL, Cavalcanti DN, Costa LJ, Diaz R, Frugulhetti IC.

Antiviral Res. 2004 Oct;64(1):69-76.

PMID:
15451181
31.

Synthesis and antiviral activities of new pyrazolo[4,3-c]quinolin-3-ones and their ribonucleoside derivatives.

de Oliveira MR, Alves TR, Pinto AC, Pereira Hde S, Leão-Ferreira LR, Moussatché N, de Frugulhetti IC, Ferreira VF, de Souza MC.

Nucleosides Nucleotides Nucleic Acids. 2004 May;23(5):735-48.

PMID:
15281362
32.

An alternative genetic method to test essential vaccinia virus early genes.

Kato SE, Greco FA, Damaso CR, Condit RC, Moussatché N.

J Virol Methods. 2004 Jan;115(1):31-40.

PMID:
14656458
33.
34.

Protein synthesis inhibitory activity in culture filtrates from new strains of Streptomyces isolated from Brazilian tropical soils.

Reis SA, Costa LV, Cavalcanti ED, Giambiagi-deMarval M, Semêdo LT, Coelho RR, Moussatché N, Damaso CR.

Lett Appl Microbiol. 2003;37(2):138-43.

35.

Accidental infection of laboratory worker with vaccinia virus.

Moussatché N, Tuyama M, Kato SE, Castro AP, Njaine B, Peralta RH, Peralta JM, Damaso CR, Barroso PF.

Emerg Infect Dis. 2003 Jun;9(6):724-6.

36.

Synthesis and antiviral evaluation of isatin ribonucleosides.

de Oliveira MR, Torres JC, Garden SJ, dos Santos CV, Alves TR, Pinto AC, Pereira Hde S, Ferreira LR, Moussatché N, Frugulhetti IC, Ferreira VF, de Souza MC.

Nucleosides Nucleotides Nucleic Acids. 2002 Nov-Dec;21(11-12):825-35.

PMID:
12537024
37.

Azathioprine inhibits vaccinia virus replication in both BSC-40 and RAG cell lines acting on different stages of virus cycle.

Damaso CR, Oliveira MF, Massarani SM, Moussatché N.

Virology. 2002 Aug 15;300(1):79-91.

38.

Inhibition of vaccinia virus replication by adenosine in BSC-40 cells: involvement of A(2) receptor-mediated PKA activation.

Leão-Ferreira LR, Paes-De-Carvalho R, De Mello FG, Moussatché N.

Arch Virol. 2002 Jul;147(7):1407-23.

PMID:
12111415
39.
40.
41.
42.

Rearrangement of intermediate filament network of BHK-21 cells infected with vaccinia virus.

Ferreira LR, Moussatché N, Moura Neto V.

Arch Virol. 1994;138(3-4):273-85.

PMID:
7998834
43.

Detection of RNA-protein complex in vaccinia virus core in vitro transcription system.

Dâmaso CR, Moussatché N.

J Gen Virol. 1992 May;73 ( Pt 5):1243-9.

PMID:
1588325
44.

Protein synthesis in vaccinia virus-infected cells. I. Effect of hypertonic shock recovery.

Dâmaso CR, Moussatché N.

Arch Virol. 1992;123(3-4):295-308.

PMID:
1562234
45.
46.
47.
48.

Core transcription restores in vitro inhibition of protein synthesis induced by vaccinia virus.

Lobo DS, Rebello MA, Moussatché N.

Biochim Biophys Acta. 1986 Dec 18;868(4):183-9.

PMID:
3790565
49.

Polyamines stimulate DNA-dependent RNA synthesis catalyzed by vaccinia virus.

Moussatché N.

Biochim Biophys Acta. 1985 Nov 13;826(2-3):113-20.

PMID:
4052428
50.

Nalidixic acid and macromolecular metabolism in Tetrahymena pyriformis: effects on protein synthesis.

de Castro JF, Carvalho JF, Moussatché N, de Castro FT.

Antimicrob Agents Chemother. 1975 May;7(5):487-93.

Supplemental Content

Loading ...
Support Center